Share

February 26, 2013; 80 (9) Article

Nonmotor fluctuations in Parkinson disease

Severity and correlation with motor complications

Alexander Storch, Christine B. Schneider, Martin Wolz, Yannic Stürwald, Angelika Nebe, Per Odin, Andreas Mahler, Gerd Fuchs, Wolfgang H. Jost, K. Ray Chaudhuri, Rainer Koch, Heinz Reichmann, Georg Ebersbach
First published January 30, 2013, DOI: https://doi.org/10.1212/WNL.0b013e318285c0ed
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
839

Share

Article Information

vol. 80 no. 9 800-809
DOI: 
https://doi.org/10.1212/WNL.0b013e318285c0ed
PubMed: 
23365054
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 3, 2012
  • Accepted October 24, 2012
  • First Published January 30, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Alexander Storch, MD,
    2. Christine B. Schneider, MD,
    3. Martin Wolz, MD,
    4. Yannic Stürwald,
    5. Angelika Nebe, MD,
    6. Per Odin, MD, PhD,
    7. Andreas Mahler, MD,
    8. Gerd Fuchs, MD,
    9. Wolfgang H. Jost, MD,
    10. K. Ray Chaudhuri, DSc, MD,
    11. Rainer Koch, MD, PhD,
    12. Heinz Reichmann, MD, PhD and
    13. Georg Ebersbach, MD
  1. Alexander Storch, MD,
    2. Scientific Advisory Boards:

    1. Member of advisory boards: Boehringer Ingelheim; Ingelheim, Germany (since 2006), Cephalon, Munich, Germany, (since 2006), Valeant Pharma, Frankfurt, Germany (since 2007), UCB Schwarz Pharma, Monheim, Germany (since 2007), Lundbeck Phrma, Hamburg, Germany, and Teva Pharma, Mörfelden-Walldorf, Germany (since 2009), Merz Pharma, Frankfurt, Germany (since 2011), Archimedes Pharma, Munich, Germany (since 2012).

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Travel money for visiting a meeting from Boehringer, Ingelheim, Germany (2009), and Teva Pharma, Mörfelden, Germany (2012).

    Editorial Boards:

    1. Editorial board member of Stem Cells, Stem Cells, International, The Open Biotechnology Journal, The European Neurological Journal

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. 1) Employment at the German Centre for Neurodegenerative, Diseases (DZNE), Dresden (non-profit, goverment institution), 2) Honoraria for presentations from Cephalon, Lundbeck, Boehringer Ingelheim, Teva, UCB, Meda, Abbott, GlaxoSmithKline, GE HealthCare, Novartis, NeuroConsil, Carus Management, Gruenenthal, Orion, Bayer HealthCare, Medtronic, SWEMODIS. Payment for manuscript preparation from Archimedes, Munich, Germany.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. I have received unrestricted research grants from Boehringer Ingelheim, Germany, Pfizer Pharma, Germany, Teva Pharma Germany, and UCB Pharma, Germany.

    Research Support, Government Entities:

    1. I have received grant money from the Bundesministerium für Bildung und Forschung, Germany, Federal Ministry of Economy, Germany, the Helmholtz Association, and the Deutsche Forschungsgemeinschaft (DFG).

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. I have received grant money from the Thyssen Foundation, Germany, the Roland-Ernst Foundation, Germany, the International Parkinson Foundation, Germany, the NA, Advocacy, UK, and the NCL foundation, Gemany.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Christine B. Schneider, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Martin Wolz, MD,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. honoraria for presentations from Boehringer Ingelheim, GlaxoSmithKline, Valeant, MEDA Pharma, Medtronic, TEVA and UCB Pharma

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Yannic Stürwald,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Angelika Nebe, MD,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Per Odin, MD, PhD,
    7. Scientific Advisory Boards:

    1. Abbott, Stada

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Abbott, UCB, Stada

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Abbott

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Andreas Mahler, MD,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Gerd Fuchs, MD,
    9. Scientific Advisory Boards:

    1. 1 UCB, 2 Boehringer, 3 Orion

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. 1 UCB, 2 Boehringer

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. Wolfgang H. Jost, MD,
    10. Scientific Advisory Boards:

    1. Scientific advisory board: Allergan, Boehringer Ingelheim,Desitin, GlaxoSmithKline, Merz

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Editor-in-chief: Basal Ganglia

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  10. K. Ray Chaudhuri, DSc, MD,
    11. Scientific Advisory Boards:

    1. Scientific advisory board for Abbott, Boehringer-Ingelheim, GSK, Serrono, Teva, UCB, Britannia pharmaceuticals between 2007-2012 and received honorarium for scientific advise.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Parkinson's disease and related disorder. Editorial board since 2009, European Editor Basal ganglia, Editorial board: Journal of Parkinson's Disease

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Honoraria for advisor in scientific advisory boards as listed above. Honoraria for lectures in international scientific meetings (EFNS, Swedish Movement Disorders Society, LIMPE Italy 2007-2009, MDS (Paris)) MDS 2010,2011, EFNS 2011, WPD 2010, WFN PRD 2011

    Consultancies:

    1. 1: PDNMG, 2: Mundipharma

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Research support for a clinical research nurse from UCB Pharma (2008-2009). Solvay (clinical fellow) Educational grant from UCB, Abbott, Boehringer for EUROPAR - an European Multicentre PD non motor studies programme

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  11. Rainer Koch, MD, PhD,
    12. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  12. Heinz Reichmann, MD, PhD and
    13. Scientific Advisory Boards:

    1. Abbott, Cephalon, Novartis, TEVA, Lundbeck, GSK, Boehringer Ingelheim, Schering/Bayer Health Care, UCB/Schwarz Pharma, Desitin, Merck-Serono, Solvay

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. for advisory board meetings or lectures. Cephalon, Novartis, TEVA, Lundbeck, GSK, Boehringer Ingelheim, Schering/Bayer Health Care, Pfizer, UCB/Schwarz Pharma, Desitin,Solvay.

    Editorial Boards:

    1. UCB/Schwarz Pharma, GSK

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Cephalon, Novartis, TEVA, Lundbeck, GSK, Boehringer Ingelheim, Schering/Bayer Health Care, Pfizer, UCB/Schwarz Pharma, Desitin,Solvay (2008/2009)

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  13. Georg Ebersbach, MD
    14. Scientific Advisory Boards:

    1. Desitin Pharma, Novartis Pharma, Boehringer Pharma, Archimedes Pharma, Orion Pharma, Britannia Pharma

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Desitin Pharma, MEDA Pharma, Glaxo SmithKline Pharma, Boehringer Pharma, Novartis Pharma, Archimedes Pharma, Orion Pharma, TEVA Pharma, UCB Pharma, Abbot Pharma

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Novartis Pharma, Archimedes Pharma, Licher GmbH, Britannia Pharma

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Deutsche Parkinson Vereinigung (patient organisation)

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Division of Neurodegenerative Diseases (A.S., C.B.S., M.W., Y.S.), Department of Medical Informatics and Biometry (R.K.), and Department of Neurology (H.R.), Dresden University of Technology, Dresden; German Center for Neurodegenerative Diseases (DZNE) (A.S.), Dresden; Movement Disorders Clinic (A.N., G.E.), Beelitz-Heilstätten; Department of Neurology (P.O., A.M.), Klinikum Bremerhaven, Bremerhaven, Germany; Department of Neurology (P.O), University Hospital, Lund, Sweden; Parkinson Clinic Wolfach (G.F.), Wolfach; Department of Neurology (W.H.J.), Deutsche Klinik für Diagnostik, Wiesbaden, Germany; and National Parkinson Foundation Centre of Excellence (K.R.C.), Kings College Hospital and Kings College London and Biomedical Research Centre, Kings College London, London, UK.
  1. Correspondence to Dr. Storch: alexander.storch{at}neuro.med.tu-dresden.de
View Full Text

Article usage

Article usage: January 2013 to January 2021

AbstractFullPdfSource
Jan 201311206Highwire
Feb 2013169151120Highwire
Mar 201314047485Highwire
Apr 20133805343Highwire
May 20132511629Highwire
Jun 20131573936Highwire
Jul 20131521623Highwire
Aug 201310569Highwire
Sep 20131031819Highwire
Oct 2013842119Highwire
Nov 20131151212Highwire
Dec 20131172210Highwire
Jan 201411789Highwire
Feb 20145779Highwire
Mar 2014981721Highwire
Apr 2014951011Highwire
May 20147089Highwire
Jun 201460129Highwire
Jul 201463118Highwire
Aug 20144284Highwire
Sep 20147669Highwire
Oct 2014831115Highwire
Nov 201463810Highwire
Dec 201461810Highwire
Jan 201565185Highwire
Feb 201570187Highwire
Mar 20157934Highwire
Apr 20154915Highwire
May 20156735Highwire
Jun 20154476Highwire
Jul 20153847Highwire
Aug 20156163Highwire
Sep 20156455Highwire
Oct 20155753Highwire
Nov 20158649Highwire
Dec 20154201Highwire
Jan 20165522Highwire
Feb 20167001Highwire
Mar 20167925Highwire
Apr 20165812Highwire
May 20163811Highwire
Jun 20164123Highwire
Jul 20164245Highwire
Aug 20164622Highwire
Sep 20163400Highwire
Oct 20165557Highwire
Nov 2016361112Highwire
Dec 20163087Highwire
Jan 20175135Highwire
Feb 20175533Highwire
Mar 20175122Highwire
Apr 20174654Highwire
May 20174356Highwire
Jun 20176412Highwire
Jul 20173710Highwire
Aug 20174311Highwire
Sep 20174933Highwire
Oct 20175132Highwire
Nov 20174311Highwire
Dec 20175149Highwire
Jan 20187534Highwire
Feb 20186052Highwire
Mar 2018130107Highwire
Apr 201813886Highwire
May 201810625Highwire
Jun 20186654Highwire
Jul 20189386Highwire
Aug 20187245Highwire
Sep 20188167Highwire
Oct 20187074Highwire
Nov 201811464Highwire
Dec 20188824Highwire
Jan 20196955Highwire
Feb 20198024Highwire
Mar 20199077Highwire
Apr 201913552Highwire
May 201910433Highwire
Jun 20199022Highwire
Jul 201911564Highwire
Aug 20196454Highwire
Sep 20198773Highwire
Oct 201911641Highwire
Nov 201913045Highwire
Dec 20198344Highwire
Jan 20203942Highwire
Feb 20208435Highwire
Mar 202010476Highwire
Apr 202011964Highwire
May 20209596Highwire
Jun 20207483Highwire
Jul 20209385Highwire
Aug 20205624Highwire
Sep 202011654Highwire
Oct 202012935Highwire
Nov 20208973Highwire
Dec 20209097Highwire
Jan 20216233Highwire

Cited By...

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me